Dipeptidyl Peptidase 4 Inhibitor [EPC]

Dipeptidyl Peptidase 4 Inhibitor [EPC] was reported 32611 times

These side effects are most commonly reported by patients taking drugs of the Dipeptidyl Peptidase 4 Inhibitor [EPC] class:

# Drug class Count
0 DIARRHOEA 2023
1 NAUSEA 1937
2 BLOOD GLUCOSE INCREASED 1872
3 ACUTE KIDNEY INJURY 1802
4 FATIGUE 1705
5 DYSPNOEA 1620
6 VOMITING 1565
7 OFF LABEL USE 1448
8 DIZZINESS 1447
9 DRUG INEFFECTIVE 1202
10 MALAISE 1147
11 HEADACHE 1137
12 PYREXIA 1083
13 ARTHRALGIA 994
14 PAIN 986
15 PRURITUS 984
16 FALL 983
17 DEHYDRATION 969
18 ASTHENIA 896
19 DEATH 838
20 HYPOGLYCAEMIA 827
21 ABDOMINAL PAIN UPPER 818
22 PNEUMONIA 802
23 WEIGHT DECREASED 788
24 LACTIC ACIDOSIS 771
25 PERIPHERAL SWELLING 767
26 ABDOMINAL DISCOMFORT 761
27 DRUG INTERACTION 761
28 CHEST PAIN 758
29 BACK PAIN 752
30 RASH 751
31 MUSCULAR WEAKNESS 731
32 COVID-19 717
33 MYOCARDIAL INFARCTION 699
34 RENAL FAILURE 689
35 ANXIETY 688
36 INSOMNIA 679
37 HYPOTENSION 676
38 ANAEMIA 675
39 GENERAL PHYSICAL HEALTH DETERIORATION 675
40 ABDOMINAL PAIN 670
41 PALPITATIONS 667
42 DECREASED APPETITE 665
43 FEELING ABNORMAL 655
44 TACHYCARDIA 651
45 HYPERHIDROSIS 610
46 ALOPECIA 592
47 URINARY TRACT INFECTION 591
48 VISUAL IMPAIRMENT 588
49 MEMORY IMPAIRMENT 580
50 CHRONIC KIDNEY DISEASE 577
51 COUGH 556
52 DIABETIC KETOACIDOSIS 553
53 CONDITION AGGRAVATED 549
54 ANGIOEDEMA 548
55 AMNESIA 535
56 OEDEMA PERIPHERAL 534
57 HEART RATE INCREASED 529
58 RENAL IMPAIRMENT 526
59 HYPERGLYCAEMIA 524
60 PAIN IN EXTREMITY 522
61 HYPERKALAEMIA 519
62 HALLUCINATION 518
63 HYPERTENSION 518
64 CONSTIPATION 514
65 COGNITIVE DISORDER 509
66 DRY SKIN 499
67 METABOLIC ACIDOSIS 495
68 CONFUSIONAL STATE 494
69 BLINDNESS 484
70 INTENTIONAL PRODUCT MISUSE 483
71 GLYCOSYLATED HAEMOGLOBIN INCREASED 479
72 DISTURBANCE IN ATTENTION 476
73 LIP SWELLING 474
74 PANCREATITIS 472
75 TOXICITY TO VARIOUS AGENTS 468
76 SUBARACHNOID HAEMORRHAGE 465
77 TRANSIENT ISCHAEMIC ATTACK 465
78 VENTRICULAR TACHYCARDIA 455
79 MIGRAINE 441
80 INTENTIONAL PRODUCT USE ISSUE 439
81 WEIGHT INCREASED 433
82 TINNITUS 427
83 DIPLOPIA 413
84 VASCULITIS 409
85 EYE PRURITUS 408
86 MUSCLE TWITCHING 407
87 PAIN OF SKIN 406
88 PRURITUS GENITAL 405
89 CAROTID ARTERY OCCLUSION 403
90 PERICARDITIS 402
91 ANOSMIA 399
92 ATRIAL TACHYCARDIA 398
93 FACIAL PAIN 397
94 CARDIOSPASM 396
95 TENSION HEADACHE 394
96 DIABETES MELLITUS 391
97 PALMOPLANTAR KERATODERMA 391
98 SLEEP TERROR 390
99 CARDIAC FAILURE 386
100 DIABETES MELLITUS INADEQUATE CONTROL 386
101 PEMPHIGOID 371
102 BLOOD PRESSURE INCREASED 370
103 SYNCOPE 358
104 CEREBROVASCULAR ACCIDENT 355
105 GAIT DISTURBANCE 352
106 SOMNOLENCE 352
107 SEPSIS 349
108 ATRIAL FIBRILLATION 335
109 MYALGIA 335
110 BLOOD CREATININE INCREASED 325
111 HAEMOGLOBIN DECREASED 318
112 EUGLYCAEMIC DIABETIC KETOACIDOSIS 317
113 RASH PAPULAR 299
114 TREMOR 281
115 HYPONATRAEMIA 277
116 PRODUCT USE ISSUE 273
117 MEDICATION ERROR 266
118 LOSS OF CONSCIOUSNESS 264
119 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 261
120 IMMUNISATION 258
121 MUSCLE SPASMS 256
122 BLOOD GLUCOSE DECREASED 255
123 URTICARIA 250
124 ERYTHEMA 249
125 BLOOD GLUCOSE ABNORMAL 248
126 DERMATITIS BULLOUS 247
127 NASOPHARYNGITIS 243
128 GASTROINTESTINAL HAEMORRHAGE 236
129 DYSPHAGIA 231
130 HAEMATOCHEZIA 228
131 GASTROINTESTINAL DISORDER 225
132 PRODUCT USE IN UNAPPROVED INDICATION 224
133 PRODUCT DOSE OMISSION ISSUE 222
134 RHABDOMYOLYSIS 220
135 DEPRESSION 219
136 CHEST DISCOMFORT 216
137 BRADYCARDIA 215
138 THROMBOCYTOPENIA 215
139 JOINT SWELLING 212
140 CARDIAC FAILURE CONGESTIVE 211
141 GASTROOESOPHAGEAL REFLUX DISEASE 210
142 PANCREATITIS ACUTE 209
143 SEPTIC SHOCK 204
144 OVERDOSE 201
145 VISION BLURRED 200
146 BLOOD PRESSURE DECREASED 199
147 PLATELET COUNT DECREASED 199
148 CONTUSION 196
149 HYPOAESTHESIA 196
150 BALANCE DISORDER 195
151 HYPERSENSITIVITY 195
152 ABDOMINAL DISTENSION 194
153 KETOACIDOSIS 194
154 FEBRILE NEUTROPENIA 192
155 CARDIAC ARREST 191
156 LETHARGY 191
157 PARAESTHESIA 191
158 ADVERSE DRUG REACTION 189
159 EPISTAXIS 188
160 INFECTION 188
161 NEUTROPENIA 188
162 CATARACT 186
163 ACUTE MYOCARDIAL INFARCTION 185
164 INJECTION SITE PAIN 183
165 NEUROPATHY PERIPHERAL 183
166 RENAL DISORDER 183
167 MOBILITY DECREASED 182
168 RESPIRATORY FAILURE 180
169 ASTHMA 179
170 INFLUENZA 177
171 DELIRIUM 176
172 HYPOMAGNESAEMIA 172
173 PULMONARY EMBOLISM 171
174 PLEURAL EFFUSION 170
175 COMPLETED SUICIDE 168
176 SINUSITIS 167
177 OROPHARYNGEAL PAIN 166
178 FUNGAL INFECTION 164
179 TUBULOINTERSTITIAL NEPHRITIS 164
180 END STAGE RENAL DISEASE 163
181 INCORRECT DOSE ADMINISTERED 162
182 DYSPEPSIA 159
183 CHILLS 157
184 TREATMENT NONCOMPLIANCE 154
185 HYPOKALAEMIA 152
186 WHITE BLOOD CELL COUNT DECREASED 152
187 POLLAKIURIA 151
188 DEPRESSED LEVEL OF CONSCIOUSNESS 149
189 OEDEMA 148
190 CELLULITIS 147
191 INTENTIONAL OVERDOSE 147
192 RHINORRHOEA 145
193 WHEEZING 144
194 DRUG HYPERSENSITIVITY 143
195 DYSURIA 143
196 INTERSTITIAL LUNG DISEASE 143
197 MUSCULOSKELETAL STIFFNESS 142
198 SEIZURE 142
199 BLISTER 141
200 TYPE 2 DIABETES MELLITUS 139
201 SHOCK 137
202 SKIN EXFOLIATION 136
203 DEPRESSED MOOD 134
204 ILLNESS 134
205 PANCREATIC CARCINOMA 134
206 DISEASE PROGRESSION 133
207 HOSPITALISATION 133
208 MUSCULOSKELETAL PAIN 133
209 PSORIASIS 133
210 FLATULENCE 131
211 DRY MOUTH 130
212 GLOMERULAR FILTRATION RATE DECREASED 130
213 PRODUCT PRESCRIBING ERROR 130
214 PULMONARY OEDEMA 130
215 MELAENA 129
216 C-REACTIVE PROTEIN INCREASED 128
217 ARTHRITIS 127
218 ANGINA PECTORIS 126
219 HAEMATURIA 125
220 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 124
221 SWELLING 123
222 DRUG INTOLERANCE 122
223 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 122
224 DYSARTHRIA 121
225 HYPOPHAGIA 121
226 MALIGNANT NEOPLASM PROGRESSION 121
227 NEPHROLITHIASIS 121
228 OXYGEN SATURATION DECREASED 121
229 BRONCHITIS 120
230 CYSTITIS 120
231 RECTAL HAEMORRHAGE 120
232 DRUG DOSE OMISSION 119
233 CARDIAC DISORDER 118
234 ARRHYTHMIA 117
235 ASPARTATE AMINOTRANSFERASE INCREASED 117
236 CHOLELITHIASIS 117
237 DISORIENTATION 117
238 PANCYTOPENIA 117
239 PRODUCTIVE COUGH 115
240 RHEUMATOID ARTHRITIS 115
241 ELECTROCARDIOGRAM QT PROLONGED 114
242 INTESTINAL OBSTRUCTION 111
243 DRUG-INDUCED LIVER INJURY 110
244 INFLUENZA LIKE ILLNESS 110
245 BLOOD PRESSURE SYSTOLIC INCREASED 109
246 BURNING SENSATION 108
247 SWELLING FACE 108
248 ACUTE RESPIRATORY FAILURE 106
249 DRUG LEVEL INCREASED 106
250 BLOOD CHOLESTEROL INCREASED 105
251 CONTRAINDICATED PRODUCT ADMINISTERED 104
252 ALANINE AMINOTRANSFERASE INCREASED 103
253 DYSPNOEA EXERTIONAL 103
254 HYPOVOLAEMIA 103
255 BLOOD UREA INCREASED 102
256 JAUNDICE 102
257 PALLOR 102
258 BLOOD CREATINE PHOSPHOKINASE INCREASED 101
259 HAEMATEMESIS 101
260 CARDIO-RESPIRATORY ARREST 100
261 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 100
262 FAECES DISCOLOURED 100
263 LEUKOCYTOSIS 100
264 NEPHROGENIC ANAEMIA 100
265 PROTEINURIA 100
266 SLEEP DISORDER 100
267 WHITE BLOOD CELL COUNT INCREASED 100
268 URINARY INCONTINENCE 99
269 DYSGEUSIA 98
270 FLUID RETENTION 98
271 PRODUCT MONITORING ERROR 98
272 RED BLOOD CELL COUNT DECREASED 98
273 UPPER GASTROINTESTINAL HAEMORRHAGE 97
274 HYPOXIA 96
275 BLOOD POTASSIUM DECREASED 95
276 CORONARY ARTERY DISEASE 95
277 THIRST 95
278 UNRESPONSIVE TO STIMULI 95
279 VERTIGO 95
280 ORTHOSTATIC HYPOTENSION 94
281 THROMBOSIS 94
282 INTERNATIONAL NORMALISED RATIO INCREASED 93
283 LOWER RESPIRATORY TRACT INFECTION 93
284 RASH PRURITIC 93
285 HAEMATOCRIT DECREASED 92
286 LEUKOPENIA 92
287 FOURNIER^S GANGRENE 91
288 HYPOCALCAEMIA 91
289 SKIN ULCER 91
290 BLOOD POTASSIUM INCREASED 90
291 HYPOACUSIS 90
292 HAEMORRHAGE 89
293 OSTEOPOROSIS 89
294 PERICARDIAL EFFUSION 89
295 RENAL INJURY 89
296 CEREBRAL INFARCTION 88
297 HEPATIC FUNCTION ABNORMAL 88
298 UNEVALUABLE EVENT 88
299 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 87
300 ALTERED STATE OF CONSCIOUSNESS 86
301 ELECTROCARDIOGRAM ABNORMAL 86
302 NECK PAIN 86
303 URINARY RETENTION 86
304 IMPAIRED GASTRIC EMPTYING 85
305 UROSEPSIS 85
306 LEFT VENTRICULAR DYSFUNCTION 84
307 MOVEMENT DISORDER 84
308 NASAL CONGESTION 84
309 SWOLLEN TONGUE 84
310 ABNORMAL LOSS OF WEIGHT 83
311 HEAD INJURY 83
312 MULTIPLE ORGAN DYSFUNCTION SYNDROME 83
313 PRODUCT QUALITY ISSUE 83
314 GAIT INABILITY 82
315 SKIN DISORDER 82
316 TACHYPNOEA 82
317 UNDERDOSE 82
318 APHASIA 81
319 GANGRENE 81
320 RASH ERYTHEMATOUS 81
321 STRESS 81
322 HAEMATOMA 80
323 HEPATIC ENZYME INCREASED 80
324 CARDIOMEGALY 79
325 DEMENTIA 79
326 GAMMA-GLUTAMYLTRANSFERASE INCREASED 79
327 INFLAMMATION 79
328 PNEUMONITIS 79
329 BLOOD TRIGLYCERIDES INCREASED 78
330 COLITIS 78
331 ELECTROLYTE IMBALANCE 78
332 GOUT 78
333 LUNG DISORDER 77
334 OSTEOARTHRITIS 77
335 UPPER RESPIRATORY TRACT INFECTION 77
336 HEPATIC STEATOSIS 76
337 RALES 76
338 AGITATION 75
339 LIMB DISCOMFORT 75
340 CYTOKINE RELEASE SYNDROME 74
341 DYSPHONIA 74
342 HYPERLACTACIDAEMIA 74
343 PNEUMONIA ASPIRATION 74
344 SKIN LESION 74
345 STOMATITIS 74
346 EOSINOPHILIA 73
347 BLOOD PRESSURE FLUCTUATION 72
348 EYE PAIN 72
349 HEART RATE IRREGULAR 72
350 SKIN DISCOLOURATION 72
351 EJECTION FRACTION DECREASED 71
352 HERPES ZOSTER 71
353 DEEP VEIN THROMBOSIS 70
354 ILL-DEFINED DISORDER 70
355 ACCIDENTAL OVERDOSE 69
356 BLOOD GLUCOSE FLUCTUATION 69
357 CEREBRAL HAEMORRHAGE 69
358 DISCOMFORT 69
359 EXERCISE TOLERANCE DECREASED 69
360 NEPHROPATHY 69
361 POLYURIA 69
362 RENAL FAILURE ACUTE 69
363 DRUG ABUSE 68
364 EATING DISORDER 68
365 WOUND 68
366 BLOOD PRESSURE INADEQUATELY CONTROLLED 67
367 HOT FLUSH 67
368 LYMPHOCYTE COUNT DECREASED 67
369 SUICIDE ATTEMPT 67
370 THERAPY INTERRUPTED 67
371 BLOOD SODIUM DECREASED 66
372 HAEMORRHOIDS 65
373 NOCTURIA 65
374 VISUAL ACUITY REDUCED 65
375 AGGRESSION 64
376 ARTERIAL OCCLUSIVE DISEASE 64
377 ANAPHYLACTIC REACTION 63
378 CLOSTRIDIUM DIFFICILE COLITIS 63
379 ECZEMA 63
380 HYPOTHYROIDISM 63
381 GASTRITIS 62
382 NEOPLASM MALIGNANT 62
383 AGRANULOCYTOSIS 61
384 CLOSTRIDIUM DIFFICILE INFECTION 61
385 HEMIPARESIS 61
386 LIVER DISORDER 61
387 NERVOUSNESS 61
388 NEUTROPHIL COUNT DECREASED 61
389 CARDIOGENIC SHOCK 60
390 DIABETIC NEUROPATHY 60
391 ACIDOSIS 59
392 COMA 59
393 FEELING HOT 59
394 PYELONEPHRITIS 59
395 RESPIRATORY TRACT INFECTION 59
396 BLADDER CANCER 58
397 FLUSHING 58
398 GASTROENTERITIS 58
399 HEPATIC FAILURE 58
400 PULMONARY HYPERTENSION 58
401 THERAPY CESSATION 58
402 BLOOD LACTIC ACID INCREASED 57
403 BONE PAIN 57
404 DYSKINESIA 57
405 INJECTION SITE HAEMORRHAGE 57
406 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 57
407 MITRAL VALVE INCOMPETENCE 57
408 PRESYNCOPE 57
409 SPUTUM DISCOLOURED 57
410 ASCITES 56
411 INCONTINENCE 56
412 MULTIPLE DRUG THERAPY 56
413 BLOOD IRON DECREASED 55
414 BREAST CANCER 55
415 ENCEPHALOPATHY 55
416 LIMB INJURY 55
417 RENAL TUBULAR NECROSIS 55
418 SUPRAVENTRICULAR TACHYCARDIA 55
419 URINE OUTPUT DECREASED 55
420 FULL BLOOD COUNT ABNORMAL 54
421 HYPOVOLAEMIC SHOCK 54
422 LIVER FUNCTION TEST ABNORMAL 54
423 MOTOR DYSFUNCTION 54
424 SINUS DISORDER 54
425 SLEEP APNOEA SYNDROME 54
426 SPEECH DISORDER 54
427 THERAPEUTIC RESPONSE UNEXPECTED 54
428 ARTERIOSCLEROSIS CORONARY ARTERY 53
429 CHROMATURIA 53
430 HAEMOPTYSIS 53
431 NO ADVERSE EVENT 53
432 RESPIRATORY TRACT CONGESTION 53
433 SINUS CONGESTION 53
434 TRICUSPID VALVE INCOMPETENCE 53
435 BLOOD BILIRUBIN INCREASED 52
436 BLOOD PRESSURE ABNORMAL 52
437 OSTEOMYELITIS 52
438 SCIATICA 52
439 TREATMENT FAILURE 52
440 AGEUSIA 51
441 ANURIA 51
442 COORDINATION ABNORMAL 51
443 COVID-19 PNEUMONIA 51
444 HEART RATE DECREASED 51
445 HEMIPLEGIA 51
446 HYPERLIPIDAEMIA 51
447 INJECTION SITE MASS 51
448 KIDNEY INFECTION 51
449 NEUTROPHIL COUNT INCREASED 51
450 PULMONARY CONGESTION 51
451 CIRCULATORY COLLAPSE 50
452 DYSSTASIA 50
453 INCORRECT PRODUCT ADMINISTRATION DURATION 50
454 LIPASE INCREASED 50
455 NEUTROPHILIA 50
456 PARKINSONISM 50
457 PRODUCT DOSE OMISSION 50
458 PULMONARY MASS 50
459 VULVOVAGINAL MYCOTIC INFECTION 50
460 ABDOMINAL PAIN LOWER 49
461 AFFECT LABILITY 49
462 DRUG ERUPTION 49
463 GASTRIC ULCER 49
464 HAEMODYNAMIC INSTABILITY 49
465 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 49
466 ORAL PAIN 49
467 TASTE DISORDER 49
468 ASPIRATION 48
469 CARDIOMYOPATHY 48
470 DIVERTICULITIS 48
471 DYSLIPIDAEMIA 48
472 EXPIRED PRODUCT ADMINISTERED 48
473 HYPERPARATHYROIDISM SECONDARY 48
474 INJECTION SITE ERYTHEMA 48
475 IRRITABILITY 48
476 LABORATORY TEST ABNORMAL 48
477 MUSCLE RIGIDITY 48
478 SENSORY LOSS 48
479 ADRENAL INSUFFICIENCY 47
480 BACTERAEMIA 47
481 CHOLESTASIS 47
482 DIALYSIS 47
483 EYE SWELLING 47
484 LOCALISED INFECTION 47
485 RASH MACULO-PAPULAR 47
486 SKIN HAEMORRHAGE 47
487 SNEEZING 47
488 THERAPEUTIC RESPONSE DECREASED 47
489 CAROTID ARTERY STENOSIS 46
490 DISSEMINATED INTRAVASCULAR COAGULATION 46
491 FRACTURE 46
492 HYPOKINESIA 46
493 JOINT INJURY 46
494 OBSTRUCTIVE AIRWAYS DISORDER 46
495 ACUTE CORONARY SYNDROME 45
496 ATRIOVENTRICULAR BLOCK 45
497 DISEASE RECURRENCE 45
498 FLANK PAIN 45
499 NEUROLEPTIC MALIGNANT SYNDROME 45
500 RASH GENERALISED 45
501 RESTLESSNESS 45
502 SUBDURAL HAEMATOMA 45
503 TOXIC EPIDERMAL NECROLYSIS 45
504 BREAST CANCER METASTATIC 44
505 CAROTID ARTERY THROMBOSIS 44
506 GASTRIC DISORDER 44
507 MYOPATHY 44
508 PRESCRIBED OVERDOSE 44
509 VENTRICULAR ARRHYTHMIA 44
510 BLOOD THYROID STIMULATING HORMONE INCREASED 43
511 BLOOD URINE PRESENT 43
512 DIABETIC METABOLIC DECOMPENSATION 43
513 FEELING COLD 43
514 HYPOGLYCAEMIC COMA 43
515 NIGHTMARE 43
516 ROAD TRAFFIC ACCIDENT 43
517 STAPHYLOCOCCAL INFECTION 43
518 VITAMIN B12 DEFICIENCY 43
519 ARTERIOSCLEROSIS 42
520 COLITIS ULCERATIVE 42
521 DIASTOLIC DYSFUNCTION 42
522 DRY EYE 42
523 GLYCOSYLATED HAEMOGLOBIN DECREASED 42
524 INFUSION RELATED REACTION 42
525 INJECTION SITE SWELLING 42
526 INTERNAL HAEMORRHAGE 42
527 LYMPHADENOPATHY 42
528 MENTAL DISORDER 42
529 POTENTIATING DRUG INTERACTION 42
530 STEVENS-JOHNSON SYNDROME 42
531 ABNORMAL BEHAVIOUR 41
532 BLOOD PRESSURE DIASTOLIC DECREASED 41
533 CHOLECYSTITIS 41
534 DEVICE ISSUE 41
535 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 41
536 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 41
537 LIVER INJURY 41
538 MUSCULOSKELETAL CHEST PAIN 41
539 OCULAR HYPERAEMIA 41
540 PLASMA CELL MYELOMA 41
541 RESPIRATORY DISTRESS 41
542 VENTRICULAR HYPOKINESIA 41
543 ANAPHYLACTIC SHOCK 40
544 BODY TEMPERATURE DECREASED 40
545 CYTOMEGALOVIRUS INFECTION 40
546 EMOTIONAL DISTRESS 40
547 EXTRA DOSE ADMINISTERED 40
548 FEMUR FRACTURE 40
549 HYPERCALCAEMIA 40
550 INJECTION SITE PRURITUS 40
551 NECROTISING FASCIITIS 40
552 NEUROTOXICITY 40
553 PROTEIN URINE PRESENT 40
554 PSYCHOTIC DISORDER 40
555 RASH MACULAR 40
556 RETCHING 40
557 SURGERY 40
558 SYSTEMIC INFECTION 40
559 ADVERSE EVENT 39
560 ATAXIA 39
561 BUNDLE BRANCH BLOCK LEFT 39
562 COLD SWEAT 39
563 DIABETIC FOOT 39
564 DRUG LEVEL ABOVE THERAPEUTIC 39
565 DRUG PRESCRIBING ERROR 39
566 ERECTILE DYSFUNCTION 39
567 ERUCTATION 39
568 HAEMOGLOBIN INCREASED 39
569 HEPATIC CIRRHOSIS 39
570 LUNG NEOPLASM MALIGNANT 39
571 MOUTH ULCERATION 39
572 PHARYNGEAL OEDEMA 39
573 PRURITUS GENERALISED 39
574 RENAL TUBULAR ACIDOSIS 39
575 AORTIC VALVE INCOMPETENCE 38
576 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38
577 GASTROENTERITIS VIRAL 38
578 HEPATITIS 38
579 INJURY 38
580 LIVER FUNCTION TEST INCREASED 38
581 MENTAL STATUS CHANGES 38
582 MUSCLE SPASTICITY 38
583 NEPHROPATHY TOXIC 38
584 PRODUCT ADMINISTRATION ERROR 38
585 SEDATION COMPLICATION 38
586 CORONARY ARTERY STENOSIS 37
587 EYE HAEMORRHAGE 37
588 HIP FRACTURE 37
589 HYPERBILIRUBINAEMIA 37
590 NIGHT SWEATS 37
591 ORAL CANDIDIASIS 37
592 PSORIATIC ARTHROPATHY 37
593 ACUTE HEPATIC FAILURE 36
594 EYE IRRITATION 36
595 HEPATOTOXICITY 36
596 HUNGER 36
597 NEUROLOGIC NEGLECT SYNDROME 36
598 PEMPHIGUS 36
599 PERIPHERAL COLDNESS 36
600 PERSONALITY DISORDER 36
601 PLATELET COUNT INCREASED 36
602 PRESCRIBED UNDERDOSE 36
603 RESPIRATORY ARREST 36
604 SUICIDAL IDEATION 36
605 VITAMIN B12 DECREASED 36
606 ACUTE MYELOID LEUKAEMIA 35
607 ADJUSTMENT DISORDER 35
608 ARTHROPATHY 35
609 BLOOD COUNT ABNORMAL 35
610 BLOOD LACTATE DEHYDROGENASE INCREASED 35
611 CANDIDA INFECTION 35
612 CARDIAC FAILURE CHRONIC 35
613 DIABETIC NEPHROPATHY 35
614 EXTRAPYRAMIDAL DISORDER 35
615 IMPAIRED HEALING 35
616 IRON DEFICIENCY ANAEMIA 35
617 PNEUMOCYSTIS JIROVECII PNEUMONIA 35
618 SINUS TACHYCARDIA 35
619 THROAT TIGHTNESS 35
620 TOE AMPUTATION 35
621 VIRAL INFECTION 35
622 ASPHYXIA 34
623 BLOOD ALKALINE PHOSPHATASE INCREASED 34
624 GENERALISED OEDEMA 34
625 NEOPLASM 34
626 NERVE INJURY 34
627 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 34
628 POLYNEUROPATHY 34
629 TOXIC ENCEPHALOPATHY 34
630 ACUTE RESPIRATORY DISTRESS SYNDROME 33
631 BODY TEMPERATURE INCREASED 33
632 EAR INFECTION 33
633 EYE DISORDER 33
634 FACIAL PARALYSIS 33
635 FREQUENT BOWEL MOVEMENTS 33
636 HYPERSOMNIA 33
637 IMMUNE-MEDIATED MYOSITIS 33
638 INJECTION SITE BRUISING 33
639 ISCHAEMIC STROKE 33
640 NEEDLE ISSUE 33
641 NEUTROPENIC SEPSIS 33
642 RESPIRATORY RATE INCREASED 33
643 RESTLESS LEGS SYNDROME 33
644 RIB FRACTURE 33
645 SHOCK HAEMORRHAGIC 33
646 SPINAL PAIN 33
647 AMYLASE INCREASED 32
648 ANGIOPATHY 32
649 BLINDNESS UNILATERAL 32
650 BLOOD ALBUMIN DECREASED 32
651 DERMATITIS 32
652 FEEDING DISORDER 32
653 HALLUCINATION, VISUAL 32
654 HIATUS HERNIA 32
655 INTERVERTEBRAL DISC PROTRUSION 32
656 METASTASES TO BONE 32
657 OLIGURIA 32
658 ONYCHOCLASIS 32
659 POOR VENOUS ACCESS 32
660 POST PROCEDURAL COMPLICATION 32
661 POST PROCEDURAL INFECTION 32
662 RENAL PAIN 32
663 ANKLE FRACTURE 31
664 ATELECTASIS 31
665 AZOTAEMIA 31
666 BLOOD CREATINE INCREASED 31
667 DIZZINESS POSTURAL 31
668 DRUG LEVEL BELOW THERAPEUTIC 31
669 HYPERNATRAEMIA 31
670 HYPERTHYROIDISM 31
671 LOWER GASTROINTESTINAL HAEMORRHAGE 31
672 MOOD ALTERED 31
673 MUCOSAL DRYNESS 31
674 MYELOSUPPRESSION 31
675 NEPHROTIC SYNDROME 31
676 NERVOUS SYSTEM DISORDER 31
677 OBESITY 31
678 ODYNOPHAGIA 31
679 PAIN IN JAW 31
680 PULMONARY FIBROSIS 31
681 SCAR 31
682 BACTERIAL INFECTION 30
683 BLOOD CHLORIDE DECREASED 30
684 BLOOD PHOSPHORUS INCREASED 30
685 BLOOD SODIUM INCREASED 30
686 DEAFNESS 30
687 DIABETIC RETINOPATHY 30
688 DYSPNOEA AT REST 30
689 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 30
690 HEPATIC NEOPLASM 30
691 HYDRONEPHROSIS 30
692 LACRIMATION INCREASED 30
693 LOW DENSITY LIPOPROTEIN DECREASED 30
694 LYMPHOPENIA 30
695 PRODUCT DISPENSING ERROR 30
696 THERAPY NON-RESPONDER 30
697 THROAT IRRITATION 30
698 THROMBOTIC MICROANGIOPATHY 30
699 ULCER 30
700 ANGINA UNSTABLE 29
701 BLOOD PRESSURE DIASTOLIC INCREASED 29
702 CHOLANGITIS 29
703 CLOSTRIDIUM TEST POSITIVE 29
704 CORONARY ARTERY OCCLUSION 29
705 GINGIVAL BLEEDING 29
706 GLAUCOMA 29
707 HELICOBACTER GASTRITIS 29
708 HYPOPHOSPHATAEMIA 29
709 LEFT VENTRICULAR HYPERTROPHY 29
710 LEG AMPUTATION 29
711 MONOCYTE COUNT INCREASED 29
712 NEOPLASM PROGRESSION 29
713 PNEUMONIA BACTERIAL 29
714 SOPOR 29
715 SPINAL FRACTURE 29
716 TORSADE DE POINTES 29
717 UPPER LIMB FRACTURE 29
718 URINE KETONE BODY PRESENT 29
719 VENTRICULAR FIBRILLATION 29
720 BLOOD MERCURY ABNORMAL 28
721 BONE DENSITY DECREASED 28
722 CARDIAC DISCOMFORT 28
723 DRUG EFFECT INCOMPLETE 28
724 ERYTHEMA MULTIFORME 28
725 FOOT FRACTURE 28
726 HEPATIC ENCEPHALOPATHY 28
727 HYPERTHERMIA 28
728 METASTASES TO LIVER 28
729 MYOCLONUS 28
730 PERICARDIAL DISEASE 28
731 PROSTATE CANCER 28
732 RED CELL DISTRIBUTION WIDTH INCREASED 28
733 SEASONAL ALLERGY 28
734 STAPHYLOCOCCAL SEPSIS 28
735 THERAPEUTIC PRODUCT EFFECT DECREASED 28
736 BALANOPOSTHITIS 27
737 CARDIAC FAILURE ACUTE 27
738 CHOKING 27
739 CROHN^S DISEASE 27
740 DECUBITUS ULCER 27
741 EOSINOPHILIC MYOCARDITIS 27
742 EPILEPSY 27
743 HYPERTENSIVE CRISIS 27
744 ILEUS 27
745 IMMUNE THROMBOCYTOPENIA 27
746 LEFT ATRIAL DILATATION 27
747 MYOCARDIAL ISCHAEMIA 27
748 REBOUND ACID HYPERSECRETION 27
749 SCHIZOPHRENIA 27
750 STENOSIS 27
751 SUSPECTED SUICIDE 27
752 ABNORMAL DREAMS 26
753 ABSCESS 26
754 ACCIDENTAL EXPOSURE TO PRODUCT 26
755 APRAXIA 26
756 CARDIAC MURMUR 26
757 CAROTID ARTERIOSCLEROSIS 26
758 CHOLESTATIC LIVER INJURY 26
759 FAECALOMA 26
760 FEELING JITTERY 26
761 FOETAL EXPOSURE DURING PREGNANCY 26
762 HAEMORRHOIDAL HAEMORRHAGE 26
763 INFARCTION 26
764 KNEE ARTHROPLASTY 26
765 MALNUTRITION 26
766 METABOLIC DISORDER 26
767 OESOPHAGEAL CANDIDIASIS 26
768 PANCREATITIS HAEMORRHAGIC 26
769 PERITONITIS 26
770 POLYDIPSIA 26
771 PRODUCT AVAILABILITY ISSUE 26
772 PRODUCT SUBSTITUTION ISSUE 26
773 RENAL CANCER 26
774 ANAEMIA MACROCYTIC 25
775 ANAL INCONTINENCE 25
776 ANHEDONIA 25
777 ATRIOVENTRICULAR BLOCK FIRST DEGREE 25
778 CONCOMITANT DISEASE AGGRAVATED 25
779 DEVICE RELATED INFECTION 25
780 EAR PAIN 25
781 FIBROMYALGIA 25
782 GALLBLADDER DISORDER 25
783 HAEMATOCRIT INCREASED 25
784 HEPATIC CYTOLYSIS 25
785 LOW DENSITY LIPOPROTEIN INCREASED 25
786 OESOPHAGITIS 25
787 ORGANISING PNEUMONIA 25
788 PARKINSON^S DISEASE 25
789 PNEUMOCYSTIS JIROVECII INFECTION 25
790 PULMONARY VALVE DISEASE 25
791 RESPIRATORY DISORDER 25
792 SUBCUTANEOUS ABSCESS 25
793 THERAPEUTIC RESPONSE SHORTENED 25
794 TOXIC SKIN ERUPTION 25
795 TRANSAMINASES INCREASED 25
796 WRONG PATIENT RECEIVED PRODUCT 25
797 ABASIA 24
798 BILE DUCT STONE 24
799 BLOOD PARATHYROID HORMONE INCREASED 24
800 CARDIOVASCULAR DISORDER 24
801 CONCUSSION 24
802 DUODENAL ULCER 24
803 EOSINOPHIL COUNT INCREASED 24
804 GROIN PAIN 24
805 HEPATIC CANCER 24
806 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 24
807 HYPOTONIA 24
808 INCREASED APPETITE 24
809 INFUSION SITE PAIN 24
810 METASTASES TO LUNG 24
811 MUSCULOSKELETAL DISCOMFORT 24
812 MYELODYSPLASTIC SYNDROME 24
813 OCCULT BLOOD 24
814 ORAL HERPES 24
815 PHARYNGITIS 24
816 ROTATOR CUFF SYNDROME 24
817 SKIN IRRITATION 24
818 TROPONIN INCREASED 24
819 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 23
820 CARDIAC OPERATION 23
821 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 23
822 COAGULOPATHY 23
823 COLON CANCER 23
824 DEMENTIA ALZHEIMER^S TYPE 23
825 DEVICE MALFUNCTION 23
826 ECHOCARDIOGRAM ABNORMAL 23
827 FACE OEDEMA 23
828 FIBROUS HISTIOCYTOMA 23
829 GASTROINTESTINAL INFLAMMATION 23
830 GENERALISED TONIC-CLONIC SEIZURE 23
831 HAEMODIALYSIS 23
832 HEPATOCELLULAR CARCINOMA 23
833 HEPATOJUGULAR REFLUX 23
834 HYPERURICAEMIA 23
835 HYPOTHERMIA 23
836 INSULIN-LIKE GROWTH FACTOR DECREASED 23
837 LUNG INFILTRATION 23
838 MOOD SWINGS 23
839 NECROSIS 23
840 PERIPHERAL ISCHAEMIA 23
841 POOR QUALITY SLEEP 23
842 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 23
843 PRODUCT DOSE OMISSION IN ERROR 23
844 PRODUCT PRESCRIBING ISSUE 23
845 PULSELESS ELECTRICAL ACTIVITY 23
846 PURPURA 23
847 SUBSTANCE USE 23
848 ATRIAL SEPTAL DEFECT 22
849 ATRIOVENTRICULAR BLOCK COMPLETE 22
850 BREAST PAIN 22
851 CARDIAC DYSFUNCTION 22
852 CHOLECYSTITIS ACUTE 22
853 DELUSION 22
854 DRUG ADMINISTRATION ERROR 22
855 DRUG RESISTANCE 22
856 ELECTROCARDIOGRAM Q WAVE ABNORMAL 22
857 FAILURE TO THRIVE 22
858 FEAR 22
859 FULL BLOOD COUNT DECREASED 22
860 GASTRITIS EROSIVE 22
861 GLOMERULONEPHRITIS MEMBRANOUS 22
862 HEAD DISCOMFORT 22
863 HYPERTRIGLYCERIDAEMIA 22
864 IMPAIRED WORK ABILITY 22
865 INTENTIONAL DOSE OMISSION 22
866 METABOLIC ALKALOSIS 22
867 MITRAL VALVE DISEASE 22
868 MUSCLE ATROPHY 22
869 NERVE COMPRESSION 22
870 ORAL MUCOSAL BLISTERING 22
871 PEPTIC ULCER 22
872 PERICARDIAL HAEMORRHAGE 22
873 PHYSICAL DECONDITIONING 22
874 PHYSICAL EXAMINATION ABNORMAL 22
875 PNEUMOTHORAX 22
876 PRODUCT STORAGE ERROR 22
877 PROSTATIC SPECIFIC ANTIGEN INCREASED 22
878 RENAL CYST 22
879 SALIVARY HYPERSECRETION 22
880 SMALL INTESTINAL OBSTRUCTION 22
881 SUBSTANCE ABUSE 22
882 SYSTOLIC DYSFUNCTION 22
883 TYPE 1 DIABETES MELLITUS 22
884 BLOOD CHOLESTEROL DECREASED 21
885 BLOOD MAGNESIUM DECREASED 21
886 BLOOD PRESSURE DIASTOLIC ABNORMAL 21
887 BLOOD URIC ACID INCREASED 21
888 DECREASED ACTIVITY 21
889 ECONOMIC PROBLEM 21
890 GASTRIC CANCER 21
891 GLUCOSE URINE PRESENT 21
892 HERNIA 21
893 LINEAR IGA DISEASE 21
894 MUSCLE TIGHTNESS 21
895 NEOPLASM SKIN 21
896 NEURALGIA 21
897 PANCREATIC DISORDER 21
898 PSYCHOLOGICAL TRAUMA 21
899 RESPIRATORY ALKALOSIS 21
900 RETINAL DETACHMENT 21
901 RETINAL HAEMORRHAGE 21
902 WRONG PRODUCT ADMINISTERED 21
903 5-HYDROXYINDOLACETIC ACID INCREASED 20
904 ASPERGILLUS INFECTION 20
905 BITE 20
906 BLINDNESS TRANSIENT 20
907 BRONCHOPULMONARY ASPERGILLOSIS 20
908 CYST 20
909 DERMATITIS ALLERGIC 20
910 DERMATITIS EXFOLIATIVE GENERALISED 20
911 DRUG DEPENDENCE 20
912 DYSAESTHESIA 20
913 GASTRIC POLYPS 20
914 GLOSSODYNIA 20
915 HYPERVOLAEMIA 20
916 IDIOPATHIC PULMONARY FIBROSIS 20
917 KETONURIA 20
918 LIGHT CHAIN ANALYSIS INCREASED 20
919 METABOLIC ENCEPHALOPATHY 20
920 MILK-ALKALI SYNDROME 20
921 MUCOSAL INFLAMMATION 20
922 MYOCARDITIS 20
923 ORTHOPNOEA 20
924 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20
925 PROSTATOMEGALY 20
926 PULMONARY ARTERIAL HYPERTENSION 20
927 SKIN CANCER 20
928 SPRUE-LIKE ENTEROPATHY 20
929 SQUAMOUS CELL CARCINOMA 20
930 TENDERNESS 20
931 TESTICULAR PAIN 20
932 URINE ABNORMALITY 20
933 VAGINAL HAEMORRHAGE 20
934 WRIST FRACTURE 20
935 ACTIVITIES OF DAILY LIVING IMPAIRED 19
936 ANGER 19
937 BRADYPHRENIA 19
938 COLITIS MICROSCOPIC 19
939 ERYSIPELAS 19
940 ESCHERICHIA INFECTION 19
941 FOOD ALLERGY 19
942 GASTRIC ULCER HAEMORRHAGE 19
943 GYNAECOMASTIA 19
944 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 19
945 INTRAVENTRICULAR HAEMORRHAGE 19
946 JOINT DISLOCATION 19
947 OROPHARYNGEAL DISCOMFORT 19
948 OSTEOPENIA 19
949 RESPIRATORY SYMPTOM 19
950 THYROID DISORDER 19
951 TOOTHACHE 19
952 TRANSFUSION 19
953 URINE CALCIUM/CREATININE RATIO INCREASED 19
954 ANTIPSYCHOTIC DRUG LEVEL INCREASED 18
955 ATROPHIC VULVOVAGINITIS 18
956 BLOOD CALCIUM DECREASED 18
957 BLOOD PRESSURE SYSTOLIC DECREASED 18
958 CARPAL TUNNEL SYNDROME 18
959 CRYING 18
960 CYANOSIS 18
961 DRUG EFFECT DECREASED 18
962 ENTEROCOLITIS 18
963 HICCUPS 18
964 JOINT STIFFNESS 18
965 KIDNEY TRANSPLANT REJECTION 18
966 LOWER LIMB FRACTURE 18
967 MATERNAL EXPOSURE DURING PREGNANCY 18
968 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 18
969 MIXED LIVER INJURY 18
970 MOUTH SWELLING 18
971 OSTEONECROSIS OF JAW 18
972 PANCREATITIS NECROTISING 18
973 POISONING 18
974 PRERENAL FAILURE 18
975 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 18
976 STUPOR 18
977 SUDDEN DEATH 18
978 TENDONITIS 18
979 URETHRAL CARUNCLE 18
980 VITAMIN D DEFICIENCY 18
981 VULVOVAGINAL PRURITUS 18
982 WEIGHT FLUCTUATION 18
983 WITHDRAWAL SYNDROME 18
984 ACNE 17
985 BASAL CELL CARCINOMA 17
986 BLOOD CALCIUM INCREASED 17
987 BLOOD CREATININE ABNORMAL 17
988 BONE DISORDER 17
989 BONE MARROW FAILURE 17
990 DEFAECATION URGENCY 17
991 DISABILITY 17
992 DISTRIBUTIVE SHOCK 17
993 DIVERTICULUM 17
994 DUODENITIS 17
995 ENTERITIS 17
996 GASTRIC HAEMORRHAGE 17
997 GASTROINTESTINAL HYPOMOTILITY 17
998 HAEMOGLOBIN ABNORMAL 17
999 HOSPICE CARE 17